Provided are a nitrogen-containing compound, an organic electroluminescent device and an electronic apparatus. The nitrogen-containing compound has a structure as shown in chemical formula 1; Ar.sub.1 and Ar.sub.2 are the same or different, and each is independently selected from a substituted or unsubstituted C6-C30 aryl, or a substituted or unsubstituted C3-C30 heteroaryl; and R.sub.0 is selected from hydrogen, a C1-C6 alkyl, a substituted or unsubstituted C6-C30 aryl, or a substituted or unsubstituted C3-C30 heteroaryl. The nitrogen-containing compound acts as a hole transporting material or a host material of a luminescent layer and can effectively improve the performance of organic electroluminescent devices.

##STR00001##

Provided are a nitrogen-containing compound, an organic electroluminescent device and an electronic apparatus. The nitrogen-containing compound has a structure as shown in chemical formula 1; Ar.sub.1 and Ar.sub.2 are the same or different, and each is independently selected from a substituted or unsubstituted C6-C30 aryl, or a substituted or unsubstituted C3-C30 heteroaryl; and R.sub.0 is selected from hydrogen, a C1-C6 alkyl, a substituted or unsubstituted C6-C30 aryl, or a substituted or unsubstituted C3-C30 heteroaryl. The nitrogen-containing compound acts as a hole transporting material or a host material of a luminescent layer and can effectively improve the performance of organic electroluminescent devices.

##STR00001##

Provided herein are compounds and pharmaceutical compositions useful for treating diseases or disorders mediated by the TRPV1 receptor. The present invention also provides methods for treating ocular diseases or disorders by administering to a subject in need thereof a therapeutically effective amount of a compound of Formula (I) or a pharmaceutical composition described herein.

##STR00001##

Disclosed are a compound containing a fused ring, a use thereof and a pharmaceutical composition containing same. Provided are a compound as shown in formula I-A, a pharmaceutically acceptable salt thereof, a solvate thereof, a solvate of the pharmaceutically acceptable salt thereof or a crystal form thereof. The compound can significantly reduce the levels of HBsAg, HBeAg and HBV DNA, and can be used for preparing a drug for treating hepatitis B, and has good market prospects. (I-A)

Disclosed is an organic light-emitting device with high efficiency and long lifespan that uses an anthracene derivative having a characteristic structure as a host compound in a light-emitting layer of the organic light-emitting device and uses a compound having a characteristic structure as a compound for an electron transport layer.

Disclosed is an organic light-emitting device with high efficiency and long lifespan that uses an anthracene derivative having a characteristic structure as a host compound in a light-emitting layer of the organic light-emitting device and uses a compound having a characteristic structure as a compound for an electron transport layer.

The disclosures herein relate to novel compounds of Formula (1): or a salt thereof, wherein X, Y, R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with General Control Nondepressible 2 (GCN2).

##STR00001##

This disclosure relates to compounds and methods of using said compounds, as well as pharmaceutical compositions containing such compounds, for treating diseases and conditions mediated by TEAD, such as cancer.

This disclosure relates to compounds and methods of using said compounds, as well as pharmaceutical compositions containing such compounds, for treating diseases and conditions mediated by TEAD, such as cancer.

The present invention relates to an organic mixture and an application thereof in organic electronic devices. The organic mixture comprises a spirofluorene organic compound containing a fused heterocyclic ring and an aromatic fused heterocyclic organic compound containing an electron-donating group. A combination of the two materials may be used as a host material of a phosphorescent organic light-emitting diode (OLED), which may use the energy of excitons and balance the charge transport to the greatest extent and which may effectively reduce the concentration of excitons and the operating voltage of a corresponding device, thereby effectively improving the efficiency and service life of the related electronic device in order to provide an effective solution for improving the overall performance of an organic electronic device.